Abstract:Purpose: To investigate possible mechanisms underlying the greater susceptibility of lipid metabolism disorders in low birth weight (LBW) mice fed with high-fat diets (HFDs).Methods: LBW mice model was established by using the pregnancy malnutrition method. Male pups were selected from LBW and normal-birth weight (NBW) offspring at random. After 3 weeks of weaning, all offspring mice were fed with HFD. Serum triglycerides (TGs), cholesterol (TC), low density lipoprotein (LDL-C), total bile acid (TAB), non-esterified fatty acid (NEFA), and mice fecal bile acid profiles were measured. Lipid deposition in liver sections was visualized by Oil Red O staining. The weight ratio of liver, muscle, and adiposity was calculated. Tandem mass tag (TMT) combined with LC-MS/MS was used to determine the differentially expressed proteins (DEPs) of liver tissue in two groups. Bioinformatics was used for further analysis of DEPs to screen key target proteins, and then Western Blot (WB) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were performed to validate the expressions of DEPs.Results: LBW mice fed with HFD showed more severe lipid metabolism disorders in the childhood. In contrast to the NBW group, the serum bile acids and fecal ω-muricholic acid (ω-MCA) levels in the LBW group were significantly lower. LC-MS/MS analysis showed that downregulated proteins were associated with lipid metabolism, and further analysis found that these proteins are mainly concentrated in peroxisome proliferation-activated receptor (PPAR) and primary bile acid synthesis signaling pathways and are involved in cellular processes and metabolic processes through binding and catalytic functions. Bioinformatics analysis indicated that the level of Cytochrome P450 Family 46 Subfamily A Member 1 (CYP46A1), PPARα, key factors of cholesterol metabolism and bile acid synthesis, as well as downstream molecules Cytochrome P450 Family 4 Subfamily A Member 14 (CYP4A14), and Acyl-Coenzyme A Oxidase 2 (ACOX2) are markedly different in the liver of LBW individuals fed with HFD, and confirmed by WB and RT-qPCR.Conclusion: LBW mice are more prone to dyslipidemia probably due to downregulated bile acid metabolism-related PPARα/CYP4A14 pathway, resulting in insufficient metabolism of cholesterol to bile acids, which, in turn, leads to elevated blood cholesterol.

Lipidomics Reveals a Link Between CYP1B1 and SCD1 in Promoting Obesity

Cytochrome P450 1B1: an Unexpected Modulator of Liver Fatty Acid Homeostasis

Cyp1b1 Deficiency Ameliorates Obesity and Glucose Intolerance Induced by High Fat Diet in Adult C57bl/6j Mice

Bile Acid Signaling in Lipid Metabolism: Metabolomic and Lipidomic Analysis of Lipid and Bile Acid Markers Linked to Anti-Obesity and Anti-Diabetes in Mice.

ROLE OF CYP1B1 IN HEPATIC LIPID METABOLISM OF ADULT MICE AND ITS POSSIBLE MECHANISM

Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity

Intestinal Stearoyl-CoA Desaturase-1 Regulates Energy Balance via Alterations in Bile Acid Homeostasis

CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model

Effect of CYP1B1 on adipose tissue angiogenic factor in young obese mice

Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity

ROLE OF CYP1B1 IN TISSUE INFLAMMATION AND MACROPHAGE INFILTRATION OF ADULT MICE

Lipidomic Profiling of High-Fat Diet-Induced Obesity in Mice: Importance of Cytochrome P450-derived Fatty Acid Epoxides.

Enhanced C/EBPβ function promotes hypertrophic versus hyperplastic fat tissue growth and prevents steatosis in response to high-fat diet feeding

The PPARα/CYP4A14 bile acid pathway is associated with lipid metabolism disorders caused by low birth weight with high-fat diet

Role of White Adipose Tissue in Protecting CYP1B1 Knock-out Mice from Obesity

Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening.

Prevention of Obesity in Mice by Antisense Oligonucleotide Inhibitors of Stearoyl-Coa Desaturase-1.

Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice

Deletion of Sphingosine Kinase 1 Ameliorates Hepatic Steatosis in Diet-Induced Obese Mice: Role of PPARγ.